183 related articles for article (PubMed ID: 14613509)
1. Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis.
Makunde WH; Kamugisha LM; Massaga JJ; Makunde RW; Savael ZX; Akida J; Salum FM; Taylor MJ
Filaria J; 2003 Nov; 2(1):15. PubMed ID: 14613509
[TBL] [Abstract][Full Text] [Related]
2. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Addiss DG; Beach MJ; Streit TG; Lutwick S; LeConte FH; Lafontant JG; Hightower AW; Lammie PJ
Lancet; 1997 Aug; 350(9076):480-4. PubMed ID: 9274584
[TBL] [Abstract][Full Text] [Related]
3. The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji.
Kimura E
Trop Med Health; 2011 Mar; 39(1):17-30. PubMed ID: 22028608
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.
Dunyo SK; Nkrumah FK; Simonsen PE
Trans R Soc Trop Med Hyg; 2000; 94(2):205-11. PubMed ID: 10897370
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.
Ismail MM; Jayakody RL; Weil GJ; Fernando D; De Silva MS; De Silva GA; Balasooriya WK
Trans R Soc Trop Med Hyg; 2001; 95(3):332-5. PubMed ID: 11491010
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.
Ismail MM; Jayakody RL; Weil GJ; Nirmalan N; Jayasinghe KS; Abeyewickrema W; Rezvi Sheriff MH; Rajaratnam HN; Amarasekera N; de Silva DC; Michalski ML; Dissanaike AS
Trans R Soc Trop Med Hyg; 1998; 92(1):94-7. PubMed ID: 9692166
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.
Turner JD; Mand S; Debrah AY; Muehlfeld J; Pfarr K; McGarry HF; Adjei O; Taylor MJ; Hoerauf A
Clin Infect Dis; 2006 Apr; 42(8):1081-9. PubMed ID: 16575724
[TBL] [Abstract][Full Text] [Related]
9. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment.
Dunyo SK; Nkrumah FK; Simonsen PE
Trans R Soc Trop Med Hyg; 2000; 94(4):437-43. PubMed ID: 11127253
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
[TBL] [Abstract][Full Text] [Related]
11. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
12. A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
Opoku NO; Doe F; Dubben B; Fetcho N; Fischer K; Fischer PU; Gordor S; Goss CW; Gyasi ME; Hoerauf A; Hong AR; Kanza E; King CL; Laryea R; Lew D; Seidu MA; Weil GJ
PLoS Negl Trop Dis; 2023 May; 17(5):e0011365. PubMed ID: 37205721
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
Keiser PB; Coulibaly YI; Keita F; Traore D; Diallo A; Diallo DA; Semnani RT; Doumbo OK; Traore SF; Klion AD; Nutman TB
Am J Trop Med Hyg; 2003 Sep; 69(3):331-5. PubMed ID: 14628953
[TBL] [Abstract][Full Text] [Related]
14. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Opoku NO; Ardrey AE; Favager S; Addy ET; Attah SK; Yamuah LK; Quartey BT
Ann Trop Med Parasitol; 2004 Sep; 98(6):595-614. PubMed ID: 15324466
[TBL] [Abstract][Full Text] [Related]
15. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations.
Shenoy RK; John A; Babu BS; Suma TK; Kumaraswami V
Ann Trop Med Parasitol; 2000 Sep; 94(6):607-14. PubMed ID: 11064762
[TBL] [Abstract][Full Text] [Related]
16. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
18. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis.
Dreyer G; Noroes J; Amaral F; Nen A; Medeiros Z; Coutinho A; Addiss D
Trans R Soc Trop Med Hyg; 1995; 89(4):441-3. PubMed ID: 7570894
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
Bjerum CM; Koudou BG; Ouattara AF; Lew D; Goss CW; Gabo PT; King CL; Fischer PU; Weil GJ; Budge PJ
PLoS Negl Trop Dis; 2023 Sep; 17(9):e0011633. PubMed ID: 37721964
[TBL] [Abstract][Full Text] [Related]
20. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH
Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
